Alterity Therapeutics Ltd 6-K, filed Sep 3, 2020
Alterity Therapeutics Ltd (ATHE)
About this 6-K
Alterity Therapeutics Ltd filed this 6-K on September 3, 2020.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2020
Alterity Therapeutics Limited
(Name of Registrant)
Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ☐ No ☒
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____
This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (File No. 333-228671) and our Registration Statements on Form F-3 (Files No. 333-220886 and 333-231417).
Alterity Therapeutics Limited
| 6-K | Items | |
| 99.1 | ||
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ALTERITY THERAPEUTICS LIMITED | ||
| (Registrant) | ||
| By: | /s/ Geoffrey Kempler | |
| Geoffrey Kempler, | ||
| Executive Chairman | ||
September 3, 2020
2
Exhibit 99.1
COMPANY ANNOUNCEMENT
(ASX: ATH)
RESULTS OF GENERAL MEETING
Thursday, 3rd September 2020
The Company wishes to advise that all resolutions contained in the Notice of Meeting were carried by proxy tally.
In accordance with ASX Listing rule 3.13.2 and Section 251AA(1) of the Corporations Act 2001, the following page provides information in relation to the proxy votes received for each resolution considered by Members of the Company at the General Meeting held today at 10:30 a.m. (AEST).
The Chairman voted undirected proxies in his control in favour of all resolutions.
On behalf of the Board
Phillip Hains
Company Secretary
Alterity Therapeutics Limited
| Level 3, 62 Lygon Street, Carlton | Page 1 of 2 | Telephone: 61 3 9824 5254 |
| Victoria Australia 3053 | Facsimile: 61 3 9822 7735 |
Alterity Therapeutics Limited
General Meeting
Thursday, 03 September 2020
Voting Results
The following information is provided in accordance with section 251AA(2) of the Corporations Act 2001 (Cth).
Page 2 of 2